ArticlePloS one2025
Spongy moths from Europe and Asia: Who could have higher invasion risk in North American?
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
North American forest systems are significantly impacted by spongy moths (Lymantria dispar Linnaeus). It is unclear, nevertheless, how are the invasion risks of spongy moths from Asia and Europe in North American relative to each other. In this study, we compared the potential ranges of spongy moths from Asia (ASM) and those from Europe (ESM) in North America, and investigated the range shifts between spongy moths in North America (NASM) and ASM and ESM. ASM and ESM would occupy larger potential ranges in North America than NASM, i.e., 7.16 and 6.98 times, respectively. Thus, one should not undervalue the invasive potential posed by spongy moths from Asia and Europe. Compared to ESM, ASM displayed larger ranges in North America. It is likely due to ASM's tolerance of more variable climates. Consequently, even though ASM was more recently introduced to North America than ESM, it's possible that the former has higher invasion risk in North American.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.